Publisher 0111

by , | Jan 1, 2011

Letter from the Publisher

Criminalizing Doctors Who Diagnose Hypothyroidism

Medical boards are responsible for taking disciplinary actions against physicians who practice medicine unprofessionally and dishonorably. Grossly repeating acts of negligence would be the basis for a board’s taking action against a practitioner. A patient presenting to the ER in extremis complaining of abdominal pain, fever, and nausea who is diagnosed with flu and sent home when acute appendicitis is afoot would be an example of negligence. A patient undergoing a nonemergent hysterectomy who has her ureter severed during surgery would be an example of negligence. A patient experiencing fatigue, cold intolerance, dryness of the skin, brittleness of the hair, low grade depression, constipation, and chronic neck and back pain diagnosed with hypothyroidism would be an example of negligence. Right? Well, yes; if that patient with a chronically low basal temperature has a normal free T4 and normal TSH, the diagnosis assuredly is not hypothyroidism. It may be depression, it may be chronic fatigue, it may be xerosis, it may be back pain, it may be constipation; but it is not hypothyroidism. Why? Because hypothyroidism is diagnosed only when the TSH is elevated and free T4 is low. It does not matter if the patient has other thyroid function tests that are abnormal. It does not matter if the patient is given an empirical trial of thyroid supplement and has a positive clinical response. It does not matter if, after having a positive clinical response to being treated with thyroid, the symptoms relapse after the thyroid treatment is discontinued. Unless the TSH is elevated and the free T4 is low, a doctor may not diagnose hypothyroidism. To make such a diagnosis would be considered gross negligence, much like misdiagnosing appendicitis in the ER or clipping the ureter during abdominal surgery.

Broda Barnes, MD, championed the “alternative” hypothyroid diagnosis a half-century ago. His writing about the diagnosis and treatment of hypothyroidism has been well appreciated by the alternative medical community. The conventional endocrinology community has loudly rejected his theories and has made the diagnosis of hypothyroidism a laboratory diagnosis treated uniformly with synthetic thyroid preparations. In fact, most thyroid screening is limited to TSH testing only. If this result is normal, no further thyroid testing is necessary and the diagnosis of hypothyroidism is ruled out. When hypothyroidism is diagnosed, treatment is always based on prescribing levothyroxine and triiodo-thyronine, never the use of thyroid USP (Armour Thyroid). Treated hypothyroid patients are monitored with TSH testing – if the TSH level is below a defined level, the diagnosis of excess thyroid treatment is made and the prescribed thyroid is reduced in dosage. The diagnosis and treatment of hypothyroidism are not predicated on patient symptoms. It does not matter if there is symptomatic improvement. The only basis for making the thyroid diagnosis and prescribing medication is by testing the serum TSH level. Such is the “state of the art” of thyroid diagnosis in 2010.

The State of Oregon v.

John E. Gambee, MD

John Gambee, MD is a physician practicing in Eugene, Oregon, who subscribes to much of the thinking espoused by Barnes. Gambee believes that the diagnosis of hypothyroidism is a clinical diagnosis made by understanding the patient history, examining the patient, assessing basal temperature, measuring thyroid functioning, and treating the patient with thyroid USP supplement. Unfortunately, the Oregon Medical Board does not share such philosophies. The Oregon board approves of thyroid diagnosis only being made based on abnormal TSH and free T4 testing.

In 1994 Gambee was disciplined by the Oregon Medical Board for “repeatedly demonstrating a willingness to move into uncharted waters in his practice without regard to the scientific merits of the proposed modality.” Gambee’s license was revoked but later reinstated. In 2004 Gambee’s license to practice medicine was subjected to a modified stipulated order. The order required Gambee to “use thyroid function blood tests in conjunction with the history and physical in making the decision whether to use thyroid medication. (Gambee) is not to use thyroid medication unless the blood tests find a TSH level greater than the normal range and a free T4 below the normal range. While treating patients (Gambee) shall periodically retest the TSH level of his patients’ blood no later than six weeks after initiating treatment and no less than annually thereafter. (Gambee) shall reduce the level of thyroid medication if the level of TSH falls below the normal range.”

In January 2010, the Oregon Medical Board opened an investigation to determine whether Gambee violated the terms of the stipulated order. In May 2010, the board served Gambee with notification that he had violated the stipulated order by not following its terms for diagnosing hypothyroidism. In September 2010, the board issued an “emergency” order suspending Gambee’s license based on his ongoing unprofessional conduct and gross negligence of diagnosing patients with hypothyroidism, exposing them to medical harm.

John Gambee is seeking to appeal the Oregon Medical Board decision. However, the board has not yet set a hearing date. Gambee is seeking relief by suing the medical board in federal court. In the interim, he is not able to practice medicine. Gambee’s case deserves to be strongly supported. There is no evidence of gross negligence – just the artificial definition that hypothyroid diagnosis must be predicated strictly on laboratory measurements. No patients treated by Gambee for hypothyroidism suffered any harm. It is inappropriate for a medical board to characterize the “alternative” treatment of hypothyroidism to be a matter of gross negligence. The endocrinology community has drawn a line in the sand, making hypothyroidism a black-and-white diagnosis when the diagnosis is not so clear-cut. The alternative community who advocates treating hypothyroidism even when blood tests are normal should stand up now and support Gambee.

Advertisement

Inquiries and support for John Gambee should be directed to him: 93224 Highway 99 S., Junction City, Oregon 97448; 541-998-0111; doctorgambee@gmail.com.

Jonathan Collin, MD

Authors

  • Jonathan Collin, MD, recently retired, published the Townsend Letter for 40+ years, contributing content regularly, as well as deciding the content and order of every single issue ever published. In addition to his work on the Townsend Letter, Dr. Collin also had a successful private medical practice, seeing patients in two different offices, before he even started the Townsend Letter. The crossover of being able to use his real-life experiences to help guide the focus in the magazine, in addition to being able to use the knowledge gleaned from the countless articles he read, served in both the long term and the short term, to help improve the lives and health of unknown numbers of patients and readers, over the decades. This knowledge and insight also helped make the Townsend Letter a magazine that was mailed out to subscribers in more than 25 different countries, helping spread knowledge, wisdom, and overall health around the globe.

    View all posts

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

When Screens Replace Connection: Impact on Children’s Brains

By Erik Peper, PhD, BCB, Stoyan Vezenkov, PhD, Violeta Manolovab, Lauren Mason, PhD and Richard Harvey, PhD – The empirical record on educational technology in early and primary education has not delivered on its promises—math and reading scores have declined while screen use in classrooms has risen, as the US NAEP data and Sweden’s recent reversal of its “digital-first” education policy make plain.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This